Browsing Tag
QURE
2 posts
uniQure’s epilepsy data could test whether its gene therapy platform can expand beyond Huntington’s disease
Find out how uniQure’s AMT-260 epilepsy data could shape QURE stock sentiment and its broader neurology gene therapy strategy.
uniQure surges 78% as FDA clears accelerated approval path for its Huntington’s disease gene therapy
uniQure (QURE) surges 78 percent as FDA clears accelerated approval path for AMT-130 in Huntington's disease, with BLA filing due Q3 2026. Full analysis.